tiprankstipranks
Lineage Cell Therapeutics, Inc. (GB:0HNF)
LSE:0HNF

Lineage Therap (0HNF) Stock Investors

1 Followers
Based on 722,487 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0HNF
On average, investors allocate 3.88% of their portfolios to GB:0HNF
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,487 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0HNF

1.1%
Last 7
Days
16.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0HNF, out of 722,487 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0HNF Investor Activity

No data currently available
Based on the activity of 13,589 investors who made their portfolios public
The table shows changes in 0HNF in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0HNF Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
+0.86%
+1.66%
40.91B
Consumer Cyclical
Coherus Biosciences
2.69%
-0.54%
-3.68%
259.48M
Healthcare
Marathon Digital Holdings
5.70%
-0.56%
+7.09%
5.90B
Financial
Riot Platforms
4.98%
+0.99%
+6.18%
2.89B
Financial
Micron
5.59%
+10.90%
+26.10%
122.04B
Technology
ChargePoint Holdings
3.95%
-1.04%
-3.27%
727.37M
Consumer Cyclical
AMC Entertainment
5.37%
-0.78%
-4.11%
1.07B
Communication Services
Plug Power
4.91%
-0.83%
+0.65%
2.33B
Industrials
Assertio Therapeutics
2.70%
-1.15%
-4.74%
98.80M
Healthcare
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Based on the activity of 722,487 active portfolios
Open your Smart Portfolio

0HNF Investor Analysis

GB:0HNF investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of GB:0HNF holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
GB:0HNF investors between 35–55

Between 35–55

15.9%
Last 30 days
Holdings Change
53.1%
of GB:0HNF holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
GB:0HNF investors over 55

Over 55

27.9%
Last 30 days
Holdings Change
35.9%
of GB:0HNF holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of GB:0HNF stock investors
See who invests in 0HNF according to age group and performance.

FAQ

How many retail Investors hold GB:0HNF?
<0.1% of TipRanks' retail investors hold GB:0HNF in their portfolios.
    What is GB:0HNF Investor Sentiment?
    GB:0HNF’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GB:0HNF in the last 7 days?
      ▲ 1.1% of TipRanks' retail investors changed their holding of GB:0HNF in the last 7 days.
        What percentage of retail investors changed their holding of GB:0HNF in the last 30 days?
        ▲ 16.8% of TipRanks' retail investors changed their holding of GB:0HNF in the last 30 days.
          What is the average age of retail investors who hold GB:0HNF?
          The average age of GB:0HNF Holders is between 35–55.
            What other stocks have GB:0HNF investors also bought?
            GB:0HNF Investors also bought DKNG, CHRS, MARA, RIOT, MU, CHPT, AMC, PLUG, ASRT, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis